Shots:
- Bio-Thera Solutions has expanded its collaboration with SteinCares, granting it exclusive rights to market a third biosimilar in Brazil and the LATAM region
- Bio-Thera will handle development, the US FDA & the EMA submissions to support LATAM regulatory filings & commercial supply of each biosimilar from its Chinese manufacturing facilities
- SteinCares will utilize its expertise in the LATAM healthcare system, strong footprint and marketing abilities to enable a go-to-market strategy, enhancing product access
Ref: Bio-Thera Solutions & SteinCares | Image: Bio-Thera Solutions & SteinCares | Press Release
Related News:- The US FDA Grants Approval to Celltrion’s Steqeyma (Biosimilar, Stelara)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
